UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma
AffiliationUniv Arizona, Coll Med Phoenix, Dept Internal Med
non-small cell lung cancer
ubiquitin-like with plant homeodomain and ring finger domains 1
MetadataShow full item record
CitationTu, Z., Deng, X., Hou, S., Feng, A., & Zhang, Q. (2020). UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma. Journal Of Cellular And Molecular Medicine. doi: 10.1111/jcmm.15438
RightsCopyright © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractAccumulating evidence suggests that ubiquitin-like with plant homeodomain and ring finger domains 1 (UHRF1) is overexpressed in non-small cell lung cancer (NSCLC); however, the expression and function of UHRF1 in the subtype of NSCLC are still unclear. Here, we investigate the expression and prognosis traits of UHRF1 in large NSCLC cohorts and explore the molecular characters during UHRF1 up-regulation. We find that UHRF1 is predominantly overexpressed in lung squamous cell carcinoma (SCC). Surprisingly, the up-regulated UHRF1 is only associated with the overall survival of lung adenocarcinoma (ADC) and knockdown of UHRF1 dramatically attenuates ADC tumorigenesis. Mechanically, we identify a hub gene that includes a total of 55 UHRF1-related genes, which are tightly associated with cell cycle pathway and yield to the poor clinical outcome in ADC patients. What's more, we observe knockdown of UHRF1 only affects ADC cells cycle and induces cell apoptosis. These results suggest that up-regulated UHRF1 only contributes to lung ADC survival by triggering cell cycle pathway, and it may be a prognostic biomarker for lung ADC patients.
NoteOpen access journal
VersionFinal published version
Except where otherwise noted, this item's license is described as Copyright © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- <i>UHRF1</i>, a Regulator of Methylation, as a Diagnostic and Prognostic Marker for Lung Cancer.
- Authors: Goto D, Komeda K, Uwatoko N, Nakashima M, Koike M, Kawai K, Kodama Y, Miyazawa A, Tanaka I, Hase T, Morise M, Hasegawa Y, Kawabe T, Sato M
- Issue date: 2020 Apr
- Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
- Authors: Liu X, Ou H, Xiang L, Li X, Huang Y, Yang D
- Issue date: 2017 Feb 7
- UHRF1 is regulated by miR-124-3p and promotes cell proliferation in intrahepatic cholangiocarcinoma.
- Authors: Zhu M, Wei C, Lin J, Dong S, Gao D, Chen J, Zhao Y, Liu B
- Issue date: 2019 Nov
- Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1).
- Authors: Dai C, Shi D, Gu W
- Issue date: 2013 Jul 5
- UHRF1 Knockdown Attenuates Cell Growth, Migration, and Invasion in Cutaneous Squamous Cell Carcinoma.
- Authors: Li Q, Chu Z, Geng S
- Issue date: 2021 Jan